Drug regulation and innovation: Empirical evidence and policy options
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Washington, D.C.
American Enterprise Inst. for Public Policy Research
1976
|
| Schriftenreihe: | Evaluative studies.
28. |
| Schlagworte: | |
| Beschreibung: | 82 S. graph. Darst. |
| ISBN: | 0844732176 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV007503164 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 930421s1976 d||| |||| 00||| eng d | ||
| 020 | |a 0844732176 |9 0-8447-3217-6 | ||
| 035 | |a (OCoLC)2538524 | ||
| 035 | |a (DE-599)BVBBV007503164 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 050 | 0 | |a HD9666.6 | |
| 082 | 0 | |a 338.4/7/61510973 | |
| 084 | |a QR 525 |0 (DE-625)142044: |2 rvk | ||
| 100 | 1 | |a Grabowski, Henry G. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Drug regulation and innovation |b Empirical evidence and policy options |
| 264 | 1 | |a Washington, D.C. |b American Enterprise Inst. for Public Policy Research |c 1976 | |
| 300 | |a 82 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Evaluative studies. |v 28. | |
| 650 | 4 | |a Industrie pharmaceutique - États-Unis | |
| 650 | 4 | |a Médicaments - Droit - États-Unis | |
| 650 | 4 | |a Médicaments - Recherche - États-Unis | |
| 650 | 4 | |a Recht | |
| 650 | 4 | |a Wirtschaft | |
| 650 | 4 | |a Drug Industry |z United States | |
| 650 | 4 | |a Drugs |x Law and legislation |z United States | |
| 650 | 4 | |a Drugs |x Research |z United States | |
| 650 | 4 | |a Economics |z United States | |
| 650 | 4 | |a Legislation, Drug |z United States | |
| 650 | 4 | |a Pharmaceutical industry |z United States | |
| 650 | 4 | |a Research |z United States | |
| 650 | 0 | 7 | |a Arzneimittelmarkt |0 (DE-588)4003131-7 |2 gnd |9 rswk-swf |
| 651 | 4 | |a USA | |
| 651 | 7 | |a USA |0 (DE-588)4078704-7 |2 gnd |9 rswk-swf | |
| 689 | 0 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
| 689 | 0 | 1 | |a Arzneimittelmarkt |0 (DE-588)4003131-7 |D s |
| 689 | 0 | |5 DE-604 | |
| 830 | 0 | |a Evaluative studies. |v 28. |w (DE-604)BV002790003 |9 28 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-004879678 | ||
Datensatz im Suchindex
| _version_ | 1804121789696049152 |
|---|---|
| any_adam_object | |
| author | Grabowski, Henry G. |
| author_facet | Grabowski, Henry G. |
| author_role | aut |
| author_sort | Grabowski, Henry G. |
| author_variant | h g g hg hgg |
| building | Verbundindex |
| bvnumber | BV007503164 |
| callnumber-first | H - Social Science |
| callnumber-label | HD9666 |
| callnumber-raw | HD9666.6 |
| callnumber-search | HD9666.6 |
| callnumber-sort | HD 49666.6 |
| callnumber-subject | HD - Industries, Land Use, Labor |
| classification_rvk | QR 525 |
| ctrlnum | (OCoLC)2538524 (DE-599)BVBBV007503164 |
| dewey-full | 338.4/7/61510973 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.4/7/61510973 |
| dewey-search | 338.4/7/61510973 |
| dewey-sort | 3338.4 17 861510973 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01786nam a2200529 cb4500</leader><controlfield tag="001">BV007503164</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">930421s1976 d||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0844732176</subfield><subfield code="9">0-8447-3217-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)2538524</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV007503164</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">HD9666.6</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4/7/61510973</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QR 525</subfield><subfield code="0">(DE-625)142044:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Grabowski, Henry G.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Drug regulation and innovation</subfield><subfield code="b">Empirical evidence and policy options</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C.</subfield><subfield code="b">American Enterprise Inst. for Public Policy Research</subfield><subfield code="c">1976</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">82 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Evaluative studies.</subfield><subfield code="v">28.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Industrie pharmaceutique - États-Unis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Droit - États-Unis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Recherche - États-Unis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Recht</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Wirtschaft</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Law and legislation</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Research</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Economics</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Legislation, Drug</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Research</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelmarkt</subfield><subfield code="0">(DE-588)4003131-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittelmarkt</subfield><subfield code="0">(DE-588)4003131-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Evaluative studies.</subfield><subfield code="v">28.</subfield><subfield code="w">(DE-604)BV002790003</subfield><subfield code="9">28</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-004879678</subfield></datafield></record></collection> |
| geographic | USA USA (DE-588)4078704-7 gnd |
| geographic_facet | USA |
| id | DE-604.BV007503164 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T17:03:34Z |
| institution | BVB |
| isbn | 0844732176 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-004879678 |
| oclc_num | 2538524 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 82 S. graph. Darst. |
| publishDate | 1976 |
| publishDateSearch | 1976 |
| publishDateSort | 1976 |
| publisher | American Enterprise Inst. for Public Policy Research |
| record_format | marc |
| series | Evaluative studies. |
| series2 | Evaluative studies. |
| spelling | Grabowski, Henry G. Verfasser aut Drug regulation and innovation Empirical evidence and policy options Washington, D.C. American Enterprise Inst. for Public Policy Research 1976 82 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Evaluative studies. 28. Industrie pharmaceutique - États-Unis Médicaments - Droit - États-Unis Médicaments - Recherche - États-Unis Recht Wirtschaft Drug Industry United States Drugs Law and legislation United States Drugs Research United States Economics United States Legislation, Drug United States Pharmaceutical industry United States Research United States Arzneimittelmarkt (DE-588)4003131-7 gnd rswk-swf USA USA (DE-588)4078704-7 gnd rswk-swf USA (DE-588)4078704-7 g Arzneimittelmarkt (DE-588)4003131-7 s DE-604 Evaluative studies. 28. (DE-604)BV002790003 28 |
| spellingShingle | Grabowski, Henry G. Drug regulation and innovation Empirical evidence and policy options Evaluative studies. Industrie pharmaceutique - États-Unis Médicaments - Droit - États-Unis Médicaments - Recherche - États-Unis Recht Wirtschaft Drug Industry United States Drugs Law and legislation United States Drugs Research United States Economics United States Legislation, Drug United States Pharmaceutical industry United States Research United States Arzneimittelmarkt (DE-588)4003131-7 gnd |
| subject_GND | (DE-588)4003131-7 (DE-588)4078704-7 |
| title | Drug regulation and innovation Empirical evidence and policy options |
| title_auth | Drug regulation and innovation Empirical evidence and policy options |
| title_exact_search | Drug regulation and innovation Empirical evidence and policy options |
| title_full | Drug regulation and innovation Empirical evidence and policy options |
| title_fullStr | Drug regulation and innovation Empirical evidence and policy options |
| title_full_unstemmed | Drug regulation and innovation Empirical evidence and policy options |
| title_short | Drug regulation and innovation |
| title_sort | drug regulation and innovation empirical evidence and policy options |
| title_sub | Empirical evidence and policy options |
| topic | Industrie pharmaceutique - États-Unis Médicaments - Droit - États-Unis Médicaments - Recherche - États-Unis Recht Wirtschaft Drug Industry United States Drugs Law and legislation United States Drugs Research United States Economics United States Legislation, Drug United States Pharmaceutical industry United States Research United States Arzneimittelmarkt (DE-588)4003131-7 gnd |
| topic_facet | Industrie pharmaceutique - États-Unis Médicaments - Droit - États-Unis Médicaments - Recherche - États-Unis Recht Wirtschaft Drug Industry United States Drugs Law and legislation United States Drugs Research United States Economics United States Legislation, Drug United States Pharmaceutical industry United States Research United States Arzneimittelmarkt USA |
| volume_link | (DE-604)BV002790003 |
| work_keys_str_mv | AT grabowskihenryg drugregulationandinnovationempiricalevidenceandpolicyoptions |